- Home
- PFE vs TMO Comparison
PFE vs TMO Comparison
Compare PFE & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PFE | TMO |
|---|---|---|
| Founded | 1849 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.6B | 164.3B |
| IPO Year | 2013 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PFE | TMO |
|---|---|---|
| Price | $26.22 | $453.51 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 18 |
| Target Price | $29.29 | ★ $636.00 |
| AVG Volume (30 Days) | ★ 26.8M | 2.2M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 6.55% | 0.40% |
| EPS Growth | N/A | ★ 7.32 |
| EPS | 0.47 | ★ 4.43 |
| Revenue | ★ $62,579,000,000.00 | $20,918,000,000.00 |
| Revenue This Year | N/A | $6.55 |
| Revenue Next Year | N/A | $5.11 |
| P/E Ratio | ★ $54.80 | $101.26 |
| Revenue Growth | N/A | ★ 14.47 |
| 52 Week Low | $23.06 | $385.46 |
| 52 Week High | $28.75 | $643.99 |
Technical Indicators
Market Signals| Indicator | PFE | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 43.79 |
| Support Level | $25.02 | $435.27 |
| Resistance Level | $26.74 | $502.20 |
| Average True Range (ATR) | 0.45 | 12.35 |
| MACD | 0.06 | 1.12 |
| Stochastic Oscillator | 63.07 | 41.17 |
Price Performance
Historical ComparisonAbout PFE Pfizer Inc.
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
About TMO Thermo Fisher Scientific Inc
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).